Sensex, Nifty start on a volatile note; Sun Pharma biggest loser among pharma stocks, tanks 10%

The Sensex settled 52.79 points or 0.15 percent higher at 36,374.08; and the broader NSE Nifty inched up 14.90 points or 0.14 percent to 10,905.20

Press Trust of India January 18, 2019 10:04:32 IST
Sensex, Nifty start on a volatile note; Sun Pharma biggest loser among pharma stocks, tanks 10%
  • There was heavy selling on pharma and banking banking counters amid weakening rupee

  • Sensex turned negative and was trading 79.53 points or 0.22% lower at 36,294.55 in early trade

  • The NSE Nifty slipped 16.25 points or 0.15% to 10,888.95

Mumbai: The BSE benchmark Sensex and NSE Nifty on Friday started on a volatile note tracking heavy selling on pharma and banking banking counters amid weakening rupee.

After opening marginally higher, the 30-share index turned negative and was trading 79.53 points, or 0.22 percent, lower at 36,294.55 in early trade.

Similarly, the NSE Nifty slipped 16.25 points, or 0.15 percent, to 10,888.95.

On Thursday, the Sensex settled 52.79 points, or 0.15 percent, higher at 36,374.08; and the broader NSE Nifty inched up 14.90 points, or 0.14 percent, to 10,905.20.

In morning session on Friday, Sun Pharma was the biggest loser on Sensex, cracking up to 10 percent.

Sensex Nifty start on a volatile note Sun Pharma biggest loser among pharma stocks tanks 10

Representational image. Reuters.

Other losers were Yes Bank, Bharti Airtel, HUL, Axis Bank, M&M, Coal India, Asian Paints, Tata Motors and TCS, shedding up to 1.49 percent.

ONGC, PowerGrid, RIL, Vedanta and Maruti were the top gainers, rising up to 1 percent.

On a net basis, foreign portfolio investors (FPIs) purchased shares worth Rs 842.13 crore Thursday, while domestic institutional investors (DIIs) were net sellers to the tune of Rs 727.46 crore, provisional data available with BSE showed.

According to analysts, global trade tensions and risk of recession will cast cloud over the sentiment; while lack of major triggers in the domestic market could steer a range bound movement in the near term.

The rupee, meanwhile, depreciated 18 paise against the US dollar to 71.21.

The benchmark Brent crude futures rose 0.88 per cent to $61.72 per barrel.

Elsewhere in Asia, Hong Kong's Hang Seng was up 0.94 percent, Shanghai Composite Index was trading 0.79 percent higher, Kospi rose 0.55 percent in early trade and Japan's Nikkei rallied 1.26 percent.

On Wall Street, Dow Jones Industrial Average ended 0.67 percent higher at 24,370.10 points on Thursday.

 

 

To keep watching India’s No. 1 English Business News Channel – CNBC-TV18, call your Cable or DTH Operator and ask for the Colors Family Pack (inclusive of 24 channels), available for Rs. 35/- per month, or subscribe to the channel for Rs. 4/- per day.

To keep watching the Leader in Global Market & Business News – CNBC-TV18 Prime HD, call your Cable or DTH Operator and ask for the Colors Family HD Pack (inclusive of 25 channels), available for Rs. 50/- per month, or subscribe to the channel for Rs. 1/- per day.

Updated Date:

also read

Market roundup: Sensex jumps by 568 points, Nifty at 18,337; today's top gainers and losers
Business

Market roundup: Sensex jumps by 568 points, Nifty at 18,337; today's top gainers and losers

Sensex increased by 568.90 points to end at 61,305.95 while Nifty ended at 18,337.90 after gaining 176.15 points.

Piramal Enterprises board approves demerger of pharma business, simplification of corporate structure
Business

Piramal Enterprises board approves demerger of pharma business, simplification of corporate structure

The pharmaceuticals business will get vertically demerged from Piramal Enterprises and consolidated under Piramal Pharma, the company said in a regulatory filing.

Opinion | Thermal power plants left with low fuel stocks, yet coal scarcity is more political than real
India

Opinion | Thermal power plants left with low fuel stocks, yet coal scarcity is more political than real

There may be some blackouts, and load-shedding power cuts have already begun in some states. But it is a crisis of our own making at best, and headed swiftly towards a solution